Trial reportThe American journal of tropical medicine and hygiene2026
Parenteral Vaccine-Induced Antibody Levels in Children with Heavy Antibiotic Exposure in Dhaka, Bangladesh.
Trial report in The American journal of tropical medicine and hygiene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Infants in resource-limited areas frequently receive early-life antibiotic treatment for respiratory and diarrheal illness, but the influence of antibiotics on parenteral vaccine immunogenicity in these settings remains underexplored. Therefore, we conducted a retrospective cohort study within a randomized, controlled, oral rotavirus and poliovirus vaccine trial performed in Dhaka, Bangladesh. Among 582 evaluable infants at 53 weeks of age, plasma antibody concentrations against measles, pertussis, diphtheria, tetanus, and Haemophilus influenzae type b (Hib) were evaluated for associations with prior antibiotic exposure. Most antibiotic prescriptions were broad-spectrum, with a mean of 85.5 days of antibiotics in the first year. Most children demonstrated protective antibody levels against measles (96%), tetanus (88%), and Hib (91%) at 53 weeks of age; fewer maintained protective levels against pertussis antigens (25-42%) and diphtheria (28%). Antibiotic exposure through 14 weeks of age, before completion of the primary vaccination series, did not significantly affect antibody concentrations at 53 weeks of age against diphtheria, tetanus, pertussis, and Hib antigens. Antibiotic exposure through 14 weeks of age was positively associated with measles antibodies at 53 weeks of age (change in concentration per antibiotic course was 9.09%; 95% CI: 5.13 to 12.75; q-value = 0.0003), but despite this association, nearly all children had protective antibody levels, limiting clinical significance. Although antibody levels varied by antigen, infant antibiotic exposure did not appear to clinically impact parenteral vaccine-induced antibody concentrations in this population. These findings support the robustness of parenteral vaccine responses in resource-limited settings despite high antibiotic use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.